Minireviews
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. May 26, 2017; 9(5): 416-421
Published online May 26, 2017. doi: 10.4330/wjc.v9.i5.416
Transcervical access, reversal of flow and mesh-covered stents: New options in the armamentarium of carotid artery stenting
Kosmas I Paraskevas, Frank J Veith
Kosmas I Paraskevas, Northern Vascular Centre, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, United Kingdom
Frank J Veith, Divisions of Vascular Surgery, New York University Langone Medical Center, New York, NY 10016, United States
Frank J Veith, the Cleveland Clinic, Cleveland, OH 44195, United States
Author contributions: Paraskevas KI came up with the idea/topic of the manuscript, searched the literature and wrote the first draft of the manuscript; Veith FJ revised the manuscript and suggested improvements.
Conflict-of-interest statement: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Kosmas I Paraskevas, MD, PhD, Northern Vascular Centre, Freeman Hospital, Freeman Road, Newcastle-upon-Tyne NE7 7DN, United Kingdom. paraskevask@hotmail.com
Telephone: +44-73-76104373
Received: December 14, 2016
Peer-review started: December 16, 2016
First decision: January 20, 2017
Revised: March 10, 2017
Accepted: March 21, 2017
Article in press: March 22, 2017
Published online: May 26, 2017
Processing time: 157 Days and 4.4 Hours
Core Tip

Core tip: Carotid artery stenting (CAS) has improved considerably in the last few years. This comprehensive review provides the various technology advances in the field that aim to reduce stroke and death rates after CAS. These include transcervical access, reversal of flow and mesh-covered stents.